-
Mashup Score: 9
Look at the science behind helping to prevent vision loss and impairment, a leading cause of disability that affects nearly 30% of the world’s population.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 9Three ways AI is changing drug discovery at AbbVie - 4 month(s) ago
Explore how artificial Intelligence can accelerate discovery of new drug targets, optimize drug design, and help get therapies to the right patients
Source: www.abbvie.comCategories: General Medicine News, PayerTweet-
Congrats Demis Hassabis, John Jumper & David Baker for the 2024 #NobelPrize in Chemistry. Their work on AlphaFold AI is making medical breakthroughs possible. See how we’re leveraging this #technology and other #AI to help discover new medicines faster: https://t.co/VYUTcZeYxn https://t.co/A5B2T3e0ev
-
-
Mashup Score: 10
Look at the science behind helping to prevent vision loss and impairment, a leading cause of disability that affects nearly 30% of the world’s population.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Neuroscience - 4 month(s) ago
AbbVie scientists are focused on how to bring better solutions and therapies to people living with neurological and psychiatric disorders.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4Three ways AI is changing drug discovery at AbbVie - 4 month(s) ago
Explore how artificial Intelligence can accelerate discovery of new drug targets, optimize drug design, and help get therapies to the right patients
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 3Immunology - 4 month(s) ago
AbbVie develops innovative medicines and therapies so patients can live more fully. Learn more about our immunology research to address chronic diseases.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Oncology Research & Treatment - 5 month(s) ago
AbbVie advances cancer research and treatment to elevate the standard of care for blood cancer patients, and in the future other cancers like solid tumors.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4Making it migraine-friendly: Why we’re reimagining the workplace - 5 month(s) ago
See how AbbVie is creating a better workplace for people with migraine, the second-most disabling condition in the world. Anna Maria Kollia still recalls the worst migraine she ever experienced at work. “I had to excuse myself from a meeting,” says Kollia, who lives in Athens, Greece, and works as eye care therapy lead for AbbVie’s Europe region. “I had to leave the office because it was extremely difficult for me to attend and concentrate during the meeting. I even took a taxi home because I wasn’t
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Then and now: A renaissance in blood cancer treatment - 5 month(s) ago
See how scientists have nearly doubled some survival rates in a generation, with even more scientific discoveries on the horizon.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 1Neuroscience - 5 month(s) ago
AbbVie scientists are focused on how to bring better solutions and therapies to people living with neurological and psychiatric disorders.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
Tips like the 20/20/20 rule can be key to protecting #vision. In collaboration with @IAPB1, we’re committed to helping preserve and protect vision because we understand its importance in everyday life. Explore our commitment to #EyeCare: https://t.co/XncPBE3KBH #WorldSightDay https://t.co/KzkGhuOXGR